Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.43 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.43 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.43 |
| ▸ | FDPS | P14324 | 9/20 | 0.41 |
| ▸ | GGPS1 | O95749 | 6/20 | 0.41 |
| ▸ | CES1 | P23141 | 4/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21087422 | 0.98 | CES2 (0.47) | CES2LPAR1LPAR3FDPSGGPS1 | |
| SCHEMBL13684033 | 0.98 | CES2 (0.47) | CES2LPAR1LPAR3FDPSGGPS1 | |
| SCHEMBL30156510 | 0.92 | CES1 (0.38) | CES2LPAR1LPAR3CES1 | |
| SCHEMBL25948178 | 0.92 | CES1 (0.38) | CES2LPAR1LPAR3CES1 | |
| SCHEMBL9976286 | 0.92 | CES1 (0.38) | CES2LPAR1LPAR3CES1 | |
| SCHEMBL28586025 | 0.84 | FDPS (0.48) | FDPSGGPS1 | |
| SCHEMBL11990032 | 0.81 | ALDH1A1 (0.35) | FDPSCES1 | |
| SCHEMBL28940804 | 0.81 | FDPS (0.50) | CES2FDPSGGPS1 | |
| SCHEMBL11990036 | 0.81 | ALDH1A1 (0.35) | FDPSCES1 | |
| SCHEMBL92887 | 0.81 | ALDH1A1 (0.35) | FDPSCES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8519073-B2 | Compound and polymeric compound | TOKYO OHKA KOGYO CO., LTD. (JP) | 2013-08-27 | — | — | US | disclosed |
| US-8105747-B2 | Positive resist composition and method of forming resist pattern | TOKYO OHKA KOGYO CO., LTD. (JP) | 2012-01-31 | — | — | US | disclosed |
| US-20100075249-A1 | POSITIVE RESIST COMPOSITION AND METHOD OF FORMING RESIST PATTERN | TOKYO OHKA KOGYO CO., LTD. (JP) | 2010-03-25 | — | — | US | disclosed |
| US-20100069590-A1 | COMPOUND AND POLYMERIC COMPOUND | TOKYO OHKA KOGYO CO., LTD. (JP) | 2010-03-18 | — | — | US | disclosed |
| EP-0681713-B1 | SULPHONIC ACID ESTERS, RADIATION-SENSITIVE MIXTURES MADE THEREWITH, AND THEIR USE | CLARIANT GMBH (DE) | 1998-11-18 | — | — | EP | disclosed |
| US-5716756-A | POSITIVE OR NEGATIVE WORKING MIXTURES | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-02-10 | — | — | US | disclosed |
| EP-0681713-A1 | SULPHONIC ACID ESTERS, RADIATION-SENSITIVE MIXTURES MADE THEREWITH, AND THEIR USE | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-11-15 | — | — | EP | disclosed |
| WO-1994018606-A1 | SULPHONIC ACID ESTERS, RADIATION-SENSITIVE MIXTURES MADE THEREWITH, AND THEIR USE | HOESCHT AKTIENGESELLSCHAFT (DE) | 1994-08-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100069590-A1 | COMPOUND AND POLYMERIC COMPOUND | AFF1, F12, AFF4 | CES2 476/4885LPAR1 1394/4885LPAR3 1373/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.